Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2013 3
2014 5
2015 6
2016 3
2017 4
2018 5
2019 5
2020 1
2021 2
2022 0
Text availability
Article attribute
Article type
Publication date

Search Results

25 results
Results by year

Citations

5 articles found by citation matching

Search results

Filters applied: . Clear all
Page 1
Recommendations for reporting of secondary findings in clinical exome and genome sequencing, 2021 update: a policy statement of the American College of Medical Genetics and Genomics (ACMG).
Miller DT, Lee K, Gordon AS, Amendola LM, Adelman K, Bale SJ, Chung WK, Gollob MH, Harrison SM, Herman GE, Hershberger RE, Klein TE, McKelvey K, Richards CS, Vlangos CN, Stewart DR, Watson MS, Martin CL; ACMG Secondary Findings Working Group. Miller DT, et al. Genet Med. 2021 Aug;23(8):1391-1398. doi: 10.1038/s41436-021-01171-4. Epub 2021 May 20. Genet Med. 2021. PMID: 34012069 No abstract available.
Recommendations for reporting of secondary findings in clinical exome and genome sequencing, 2016 update (ACMG SF v2.0): a policy statement of the American College of Medical Genetics and Genomics.
Kalia SS, Adelman K, Bale SJ, Chung WK, Eng C, Evans JP, Herman GE, Hufnagel SB, Klein TE, Korf BR, McKelvey KD, Ormond KE, Richards CS, Vlangos CN, Watson M, Martin CL, Miller DT. Kalia SS, et al. Genet Med. 2017 Feb;19(2):249-255. doi: 10.1038/gim.2016.190. Epub 2016 Nov 17. Genet Med. 2017. PMID: 27854360 Free article.
It also would be prudent to consider whether intellectual property interests may restrict the performance of certain tests and other procedures.To promote standardized reporting of actionable information from clinical genomic sequencing, in 2013, the A …
It also would be prudent to consider whether intellectual property interests may restrict the performance of certain tests and other procedu …
ACMG recommendations for reporting of incidental findings in clinical exome and genome sequencing.
Green RC, Berg JS, Grody WW, Kalia SS, Korf BR, Martin CL, McGuire AL, Nussbaum RL, O'Daniel JM, Ormond KE, Rehm HL, Watson MS, Williams MS, Biesecker LG; American College of Medical Genetics and Genomics. Green RC, et al. Genet Med. 2013 Jul;15(7):565-74. doi: 10.1038/gim.2013.73. Epub 2013 Jun 20. Genet Med. 2013. PMID: 23788249 Free PMC article.
In clinical exome and genome sequencing, there is a potential for the recognition and reporting of incidental or secondary findings unrelated to the indication for ordering the sequencing but of medical value for patient …
In clinical exome and genome sequencing, there is a potential for the recognition and reporting of inc
Performance of ACMG-AMP Variant-Interpretation Guidelines among Nine Laboratories in the Clinical Sequencing Exploratory Research Consortium.
Amendola LM, Jarvik GP, Leo MC, McLaughlin HM, Akkari Y, Amaral MD, Berg JS, Biswas S, Bowling KM, Conlin LK, Cooper GM, Dorschner MO, Dulik MC, Ghazani AA, Ghosh R, Green RC, Hart R, Horton C, Johnston JJ, Lebo MS, Milosavljevic A, Ou J, Pak CM, Patel RY, Punj S, Richards CS, Salama J, Strande NT, Yang Y, Plon SE, Biesecker LG, Rehm HL. Amendola LM, et al. Am J Hum Genet. 2016 Jun 2;98(6):1067-1076. doi: 10.1016/j.ajhg.2016.03.024. Epub 2016 May 12. Am J Hum Genet. 2016. PMID: 27181684 Free PMC article.
Nine molecular diagnostic laboratories involved in the Clinical Sequencing Exploratory Research (CSER) consortium piloted these guidelines on 99 variants spanning all categories (pathogenic, likely pathogenic, uncertain significance, likely benign, and benign …
Nine molecular diagnostic laboratories involved in the Clinical Sequencing Exploratory Research (CSER) consortium pilot …
On the justifiability of ACMG recommendations for reporting of incidental findings in clinical exome and genome sequencing.
May T. May T. J Law Med Ethics. 2015 Spring;43(1):134-42. doi: 10.1111/jlme.12201. J Law Med Ethics. 2015. PMID: 25846044
This paper examines three possible justifications for original ACMG recommendations to return incidental findings from whole exome or genome sequencing independent of patient preferences. The first two potential justifications, bas …
This paper examines three possible justifications for original ACMG recommendations to return incidental findings
Reporting Incidental Findings in Clinical Whole Exome Sequencing: Incorporation of the 2013 ACMG Recommendations into Current Practices of Genetic Counseling.
Smith LA, Douglas J, Braxton AA, Kramer K. Smith LA, et al. J Genet Couns. 2015 Aug;24(4):654-62. doi: 10.1007/s10897-014-9794-4. Epub 2014 Nov 18. J Genet Couns. 2015. PMID: 25403901
The purpose of this study was to investigate how the American College of Medical Genetics and Genomics (ACMG) March 2013 recommendations for reporting incidental findings (IFs) have influenced current practices of genetic counselors invol …
The purpose of this study was to investigate how the American College of Medical Genetics and Genomics (ACMG) March 2013 re
Minimizing liability risks under the ACMG recommendations for reporting incidental findings in clinical exome and genome sequencing.
Evans BJ. Evans BJ. Genet Med. 2013 Dec;15(12):915-20. doi: 10.1038/gim.2013.135. Epub 2013 Sep 12. Genet Med. 2013. PMID: 24030435 Free PMC article.
Recent recommendations by the American College of Medical Genetics and Genomics (ACMG) for reporting incidental findings present novel ethical and legal issues. ...To a considerable degree, liability risks can be controlled by structuring …
Recent recommendations by the American College of Medical Genetics and Genomics (ACMG) for reporting incident
Clinical genome sequencing and population preferences for information about 'incidental' findings-From medically actionable genes (MAGs) to patient actionable genes (PAGs).
Ploug T, Holm S. Ploug T, et al. PLoS One. 2017 Jul 3;12(7):e0179935. doi: 10.1371/journal.pone.0179935. eCollection 2017. PLoS One. 2017. PMID: 28671958 Free PMC article.
Whole genome or exome sequencing is increasingly used in the clinical contexts, and 'incidental' findings are generated. There is need for an adequate policy for the reporting of these findings to individuals. Such a policy …
Whole genome or exome sequencing is increasingly used in the clinical contexts, and 'incidental' findi
Current controversies in prenatal diagnosis 2: The 59 genes ACMG recommends reporting as secondary findings when sequencing postnatally should be reported when detected on fetal (and parental) sequencing.
Amor DJ, Chitty LS, Van den Veyver IB. Amor DJ, et al. Prenat Diagn. 2020 Dec;40(12):1508-1514. doi: 10.1002/pd.5670. Epub 2020 Apr 17. Prenat Diagn. 2020. PMID: 32091628
However, with clinical exome and genome sequencing, there is potential for the recognition and reporting of incidental or secondary findings unrelated to the indication for ordering the sequencing, but of potential medical v …
However, with clinical exome and genome sequencing, there is potential for the recognition and reporting
25 results